iZO Promo Review
Fictional brands · Sample data as of 12 Oct 2026
Claims by status
1Expiring in under 60 days

Claim C-004

One governed record per claim. Approved once with its risk information, then reused in every piece.

Claim record · Brand X (illustrative)

Claim text
[Outcome C] in patients with [subgroup] in [Study 2]
Reference
[Study 2] prespecified subgroup analysis, Table [x]; PI Section 14.2
Risk information
ISI-02 · Brand X Important Risk Information (IRI) — HCP short form v2
Status
Expiring in under 60 days
Expiry date
18 Nov 202637 days from 12 Oct 2026
Message strength
68Score from message testing (placeholder)
Audience and channelProposed field
HCP specialist · Sales aid
Treatment stageProposed field
Special populations

Fair balanced claim — reviewed and approved as a pair

Claim C-004

[Outcome C] in patients with [subgroup] in [Study 2]

ISI-02

Approved

Brand X Important Risk Information (IRI) — HCP short form v2

[Condensed IRI placeholder for digital/short-form use]

Shown with the claim in every pieceStored once, linked to 2 claims. Terms vary by company: ISI, IRI or fair balance language.

Status

New
Review
Approved
Modified
● Expiring <60 days
Prior approval expired
FDA removed
Sign-off:

Status history

  1. 19 Sept 2026 — Marked Expiring in under 60 days — added to review queueMarketing ops coordinator
  2. 18 Nov 2025 — Approved — expiry date setMarketing ops coordinator
  3. 27 Oct 2025 — Sent to review (Medical, Regulatory, Legal)Marketing ops coordinator
  4. 6 Oct 2025 — Created as New, reference attachedMarketing ops coordinator

Used in pieces (1)

Design rules

  • Smallest approvable unit — if two claims must always appear together, they become one claim.
  • Risk information stored once — fair balance and safety language is linked to claims, not copied.
  • One record, many pieces.

What moves a status

  • • Expiry date approaching or passed
  • • Label updates: new data, indications, boxed warnings, monitoring
  • • FDA actions
  • • Removal letters

Every return to Approved passes through Medical, Regulatory and Legal.